Why it is studied
KLOW combines BPC-157, GHK-Cu, TB-500 and KPV in one declared material. Its research context brings together tissue-signalling and inflammatory-response models studied separately for the individual components.

Presentation mock-up for KLOW — BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg + KPV 10 mg. The batch, COA and final commercial packaging will be confirmed before launch.
A declared four-component blend. Commercial release requires individual and combined composition verification.
The price is published for catalogue purposes. Any quote or sale depends on product availability, batch-document verification and buyer-eligibility checks.
KLOW combines BPC-157, GHK-Cu, TB-500 and KPV in one declared material. Its research context brings together tissue-signalling and inflammatory-response models studied separately for the individual components.
KPV is a tripeptide derived from the C-terminal region of alpha-MSH, while the other components have distinct profiles. Interactions within the blend must be evaluated directly rather than assumed from data on each ingredient.
There is no basis for mathematically combining results from separate studies. Identity, proportions, stability and blend homogeneity must be demonstrated for the final batch.
This summary is informational and describes research context; it is not a medical claim or recommendation for use.
Exact storage and handling conditions must come exclusively from the verified batch data sheet and COA.
No reconstitution, dosing, injection, human-use instructions are provided.
No certificate is published for this product in the staging version. A COA will appear only if it is authentic, verified and linked to the batch offered.
Conditions depend on product classification, transport requirements and destination eligibility. See our delivery and returns page.
Scientific context for Skin Glow (GHK-Cu), evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for BPC-157, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →Scientific context for TB-500, evidence limitations and the batch documents that should be checked before an experiment.
Read the article →
A copper–tripeptide complex used in laboratory models concerning signalling and the extracellular matrix.
50 mg

A 100 mg configuration of the GHK-Cu complex for laboratory research use only.
100 mg

A synthetic 15-amino-acid peptide investigated in preclinical tissue-signalling models.
5 mg
No. Products labelled RUO are exclusively for research and are not intended for use in humans.
Prices are visible, but sale remains blocked until each product passes legal review, its documentation is checked and buyer eligibility is confirmed.
Yes, but only when they are authentic, batch-linked and verifiable. We do not publish generic certificates or invented percentages.
Add products to the cart and complete the professional eligibility form. An enquiry does not guarantee a sale.
The content and catalogue are intended for eligible professionals, laboratories and research organisations.
Read the full noticeReceive a code for the first order that passes eligibility and legal-availability checks.